Qinghai Spring Medicinal Resources Technology Co., Ltd.

SHSE:600381 Stock Report

Market Cap: CN¥1.8b

Qinghai Spring Medicinal Resources Technology Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Qinghai Spring Medicinal Resources Technology.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals earnings growth18.6%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Qinghai Spring Medicinal Resources Technology Co., Ltd.'s (SHSE:600381) Share Price Is Still Matching Investor Opinion Despite 30% Slump

Jun 24
Qinghai Spring Medicinal Resources Technology Co., Ltd.'s (SHSE:600381) Share Price Is Still Matching Investor Opinion Despite 30% Slump

Qinghai Spring Medicinal Resources Technology Co., Ltd.'s (SHSE:600381) 26% Cheaper Price Remains In Tune With Revenues

May 09
Qinghai Spring Medicinal Resources Technology Co., Ltd.'s (SHSE:600381) 26% Cheaper Price Remains In Tune With Revenues

Qinghai Spring Medicinal Resources Technology Co., Ltd.'s (SHSE:600381) 27% Price Boost Is Out Of Tune With Revenues

Mar 12
Qinghai Spring Medicinal Resources Technology Co., Ltd.'s (SHSE:600381) 27% Price Boost Is Out Of Tune With Revenues

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Qinghai Spring Medicinal Resources Technology has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

SHSE:600381 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/2024245-2775866N/A
3/31/2024242-2665165N/A
12/31/2023214-2681024N/A
9/30/2023192-282-14-3N/A
6/30/2023162-289-48-40N/A
3/31/2023141-293-39-38N/A
12/31/2022160-288-33-32N/A
9/30/2022175-264-9-8N/A
6/30/2022186-248-21-19N/A
3/31/2022183-263-59-56N/A
12/31/2021128-249-186-64N/A
9/30/2021143-276-309-68N/A
6/30/2021138-305-320-78N/A
3/31/2021132-311-392-74N/A
12/31/2020124-320-276-78N/A
9/30/2020128-69-178-97N/A
6/30/2020135-61-203-122N/A
3/31/2020174-20-223-218N/A
12/31/20192346-242-236N/A
9/30/2019248-25-302-300N/A
6/30/2019277-11-355-333N/A
3/31/201930533-241-218N/A
12/31/201833368-227-184N/A
9/30/2018358186-110-67N/A
6/30/20184413091537N/A
3/31/2018452316N/A93N/A
12/31/2017471311N/A94N/A
9/30/2017646346N/A403N/A
6/30/2017671275N/A452N/A
3/31/2017705260N/A347N/A
12/31/2016708245N/A345N/A
9/30/2016876255N/A393N/A
6/30/20161,115352N/A616N/A
3/31/20161,187365N/A723N/A
12/31/20151,402358N/A832N/A
9/30/20151,466242N/A276N/A
6/30/20151,527225N/A-327N/A
3/31/20151,844285N/A-137N/A
12/31/20142,063365N/A-152N/A
12/31/20132,141337N/A671N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 600381's forecast earnings growth is above the savings rate (2.9%).

Earnings vs Market: Insufficient data to determine if 600381's earnings are forecast to grow faster than the CN market

High Growth Earnings: Insufficient data to determine if 600381's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if 600381's revenue is forecast to grow faster than the CN market.

High Growth Revenue: Insufficient data to determine if 600381's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if 600381's Return on Equity is forecast to be high in 3 years time


Discover growth companies